You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2025

Details for Patent: 10,874,664


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,874,664
Title:Bupropion as a modulator of drug activity
Abstract: Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.
Inventor(s): Tabuteau; Herriot (New York, NY)
Assignee: ANTECIP BIOVENTURES II LLC (New York, NY)
Application Number:16/823,724
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,874,664: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to understand its significance, validity, and potential impact. This article will provide a detailed analysis of United States Patent 10,874,664, focusing on its claims, scope, and the relevant patent landscape.

Patent Overview

United States Patent 10,874,664, like any other patent, is a grant of rights for an invention, issued by the United States Patent and Trademark Office (USPTO). To analyze this patent, one must first understand the invention it describes.

Claims Analysis

Claim Structure

Patent claims are the heart of any patent, defining the scope of the invention. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[5].

  • Independent Claims: These claims define the invention in its broadest terms and are crucial for determining the patent's scope. For example, if a patent has multiple independent claims, each claim may cover different aspects of the invention.
  • Dependent Claims: These claims narrow down the invention further by adding additional limitations to the independent claims.

Claim Language and Scope

The language used in the claims is critical. It must be clear and definite to inform those skilled in the art what is and is not covered by the patent. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process than broader claims[3].

Patent Scope

Metrics for Measuring Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in understanding the breadth and clarity of the patent claims.

  • Independent Claim Length: Longer independent claims often indicate more complex inventions or attempts to cover a broader scope.
  • Independent Claim Count: A higher number of independent claims can suggest a more comprehensive coverage of the invention[3].

Impact on Innovation

The scope of a patent can significantly impact innovation. Overly broad patents can lead to increased licensing and litigation costs, potentially diminishing incentives for further innovation. Conversely, well-defined and narrow patents can foster a clearer understanding of what is protected, encouraging more innovation around the patented technology[3].

Patent Landscape

Family Members and Continuations

Patents often have family members, including continuations, continuations-in-part, and divisional applications. These related patents can complicate the landscape, especially when dealing with issues like obviousness-type double patenting (ODP)[1].

  • Continuations and Continuations-in-Part: These are new patent applications that claim priority from an earlier application. They can extend the patent term but must avoid ODP issues.
  • Divisional Applications: These are used when an original application contains multiple inventions and needs to be split into separate patents.

Patent Term Adjustment (PTA) and Terminal Disclaimers

Patent Term Adjustment (PTA) can extend the term of a patent due to delays in the USPTO's processing. However, terminal disclaimers, often used to overcome ODP rejections, can affect the patent term. The court has clarified that PTA does not extend the term past the date of a terminal disclaimer[1].

Global Patent System

The global patent system is increasingly interconnected. Tools like the Global Dossier and Common Citation Document (CCD) facilitate the search and analysis of related patent applications across different jurisdictions, helping to ensure consistency and reduce duplication[4].

Litigation and Enforcement

Patent Trolls and Anti-Troll Laws

Patent trolls, entities that primarily engage in patent litigation, can significantly impact the patent landscape. Laws and regulations, such as those supported by Attorney General Josh Stein, aim to protect innovators from bad-faith patent infringement claims. These laws are crucial in maintaining a healthy innovation ecosystem[2].

Claim Construction and Indefiniteness

Claim construction is a critical aspect of patent litigation, determining the scope of the invention. The Federal Circuit has emphasized that claim construction is a question of law, reviewed de novo on appeal. Indefiniteness, which can render a claim invalid, is also a legal conclusion reviewed de novo[5].

Key Takeaways

  • Clear Claims: The clarity and definiteness of patent claims are essential for determining the scope of the invention and avoiding indefiniteness issues.
  • Patent Scope Metrics: Independent claim length and count can provide valuable insights into the breadth and clarity of a patent.
  • Patent Family Complexity: Understanding the relationships between family members, including continuations and divisional applications, is crucial for navigating ODP and PTA issues.
  • Global Interconnectedness: Tools like the Global Dossier and CCD are vital for managing the global patent landscape.
  • Litigation and Enforcement: Laws against patent trolls and proper claim construction are essential for protecting innovators and maintaining patent validity.

FAQs

What are the key components of a patent claim?

The key components include independent claims that define the invention broadly and dependent claims that narrow down the invention by adding additional limitations.

How does the scope of a patent impact innovation?

Overly broad patents can increase licensing and litigation costs, diminishing innovation incentives. Well-defined and narrow patents can foster clearer understanding and encourage innovation.

What is the role of Patent Term Adjustment (PTA) in patent law?

PTA extends the term of a patent due to USPTO processing delays but does not extend the term past the date of a terminal disclaimer.

How do anti-patent troll laws protect innovators?

These laws allow targets of bad-faith patent infringement claims to bring counterclaims against patent trolls, protecting innovators from harassment and legal wrangling.

What is the significance of claim construction in patent litigation?

Claim construction determines the scope of the invention and is reviewed de novo on appeal. It is crucial for avoiding indefiniteness issues and ensuring the validity of the patent.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Attorney General Josh Stein Leads Coalition Fighting Against Patent Trolls, North Carolina Department of Justice.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Search for Patents, USPTO.
  5. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC., United States Court of Appeals for the Federal Circuit, September 16, 2024.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,874,664

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Axsome AUVELITY bupropion hydrochloride; dextromethorphan hydrobromide TABLET, EXTENDED RELEASE;ORAL 215430-001 Aug 18, 2022 RX Yes Yes ⤷  Try for Free ⤷  Try for Free DEXTROMETHORPHAN AND BUPROPION IN COMBINATION TO TREAT MAJOR DEPRESSIVE DISORDER ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,874,664

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014346807 ⤷  Try for Free
Australia 2015350559 ⤷  Try for Free
Australia 2018203638 ⤷  Try for Free
Australia 2019201548 ⤷  Try for Free
Australia 2019223187 ⤷  Try for Free
Australia 2019236614 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.